Mustang Bio
MBIO
35 hedge funds and large institutions have $7.25M invested in Mustang Bio in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
3% less funds holding
Funds holding: 36 → 35 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
54% less capital invested
Capital invested by funds: $15.8M → $7.25M (-$8.59M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
+$155K |
| 2 |
Renaissance Technologies
New York
|
+$146K |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$66.9K |
| 4 |
SG Americas Securities
New York
|
+$51.7K |
| 5 |
Bank of New York Mellon
New York
|
+$48.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.08M |
| 2 |
State Street
Boston,
Massachusetts
|
-$73K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$66.9K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$51.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$39.5K |
MBIO Hedge Fund Activity: Q4 2018 in Review
35 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2018, worth a combined $7.25M — down 54% from $15.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MBIO and 4 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 8 added.
The largest buyer was Fenimore Asset Management, opening a new position worth an estimated $155K. The largest seller was Vanguard Group, cutting an estimated $1.08M.
- 35 institutional investors held Mustang Bio (MBIO) as of Q4 2018, down from 36 in Q3 2018.
- Funds reported $7.25M of Mustang Bio stock for Q4 2018, down 54% quarter-over-quarter.
- 4 funds opened new Mustang Bio positions in Q4 2018 and 5 closed out, a net change of -1 holder.
- The largest Mustang Bio buyer in Q4 2018 was Fenimore Asset Management, an estimated $155K added.
- The largest Mustang Bio seller in Q4 2018 was Vanguard Group, an estimated $1.08M sold.
Based on aggregated 13F filings for Q4 2018.